Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Total Debt (2018 - 2023)

Avai Bio's Total Debt history spans 6 years, with the latest figure at $99000.0 for Q4 2023.

  • On a quarterly basis, Total Debt fell 54.31% to $99000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $99000.0, a 54.31% decrease, with the full-year FY2023 number at $198000.0, up 100.0% from a year prior.
  • Total Debt hit $99000.0 in Q4 2023 for Avai Bio, roughly flat from $99000.0 in the prior quarter.
  • Over the last five years, Total Debt for AVAI hit a ceiling of $216668.0 in Q4 2022 and a floor of -$480.0 in Q2 2020.
  • Historically, Total Debt has averaged $86659.5 across 5 years, with a median of $99000.0 in 2022.
  • Biggest five-year swings in Total Debt: tumbled 100.47% in 2020 and later surged 2262.81% in 2021.
  • Tracing AVAI's Total Debt over 5 years: stood at $186984.0 in 2019, then tumbled by 84.42% to $29141.0 in 2020, then tumbled by 76.25% to $6921.0 in 2021, then surged by 3030.59% to $216668.0 in 2022, then plummeted by 54.31% to $99000.0 in 2023.
  • Business Quant data shows Total Debt for AVAI at $99000.0 in Q4 2023, $99000.0 in Q3 2023, and $99000.0 in Q2 2023.